Both in Pharmaceuticals
Innoviva vs Ocular Therapeutix
Over the past year INVA returned +17.1% and OCUL returned −34.5%; their daily moves had a correlation of 0.10.
INVA +17.1% OCUL −34.5%Growth of $1, one year, split-adjusted
| Metric | INVA | OCUL |
|---|---|---|
| Price | $21.26 | $7.14 |
| Market cap | $1.54B | $1.57B |
| Today | +1.58% | +4.69% |
| 1 month | +2.1% | −2.7% |
| 6 months | −5.6% | −26.5% |
| Year to date | +6.4% | −41.2% |
| 1 year | +17.4% | −37.4% |
| Revenue growth (YoY) | +19.3% | +0.1% |
| Gross margin | 81.3% | 85.1% |
| Net margin | −69.8% | −584.5% |
| P/E (TTM) | 4.3× | — |
| Price / sales | 3.5× | 30.1× |
| Net cash | $319.0M | $525.8M |
| Dividend yield | — | — |
| Volatility (60d) | 21.1% | 75.4% |
| Short % of float | 10.5% | 15.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).